| Educational Programme Module |
Multinational Clinical Research Organization |
Diabetic Macular Edema Understanding and Management |
Diabetic Macular Edema, Imaging, Biomarkers and Anti-VEGF Management |
Glaucoma Risk Factors and Management |
Dry Eye Diagnosis and Treatment |
Unmet Needs in Glaucoma |
Retinal Dystrophies |
| AVAILABLE |
AVAILABLE |
AVAILABLE |
AVAILABLE |
AVAILABLE |
AVAILABLE |
NOW AVAILABLE |
| Webinars Title |
Webinar #1 How to setup a clinical research study |
Webinar #4 DME definition, classification and imaging |
Webinar #4 DME definition, classification and imaging |
Webinar #8 Landmark clinical trials in glaucoma |
Webinar #11 Dry eye syndrome: signs and symptoms |
Webinar #14 Patient compliance and IOP telemetry |
Webinar #17 Inherited Retinal Dystrophies: Overview, Causative Genes and Diagnostic Approach |
Webinar #20 Macular Dystrophies |
Webinar #23 Genetic Diagnostics in IRDs |
| Webinar #2 Clinical research organization |
Webinar #5 Predicting progression and treatment response |
Webinar #5 Predicting progression and treatment response |
Webinar#9 Risk factors in glaucoma |
Webinar #12 Diagnosis in dry eye syndrome |
Webinar #15 Non-IOP dependent strategies |
Webinar #18 Retinitis Pigmentosa and Gene Therapy |
Webinar #21 Functional Diagnostics of the Retina in IRDs |
|
| Webinar #3 SOPs – quality and certification |
Webinar #6 Treatment of DME |
Webinar #7 Anti-VEGF treatment of DME |
Webinar #10 Glaucoma: Who to treat and when |
Webinar #13 Treatment of dry eye syndrome |
Webinar #16 Surrogate markers and outcome measures and early diagnosis |
Webinar #19 Differential Diagnostics of Juvenile and Childhood Genetic Diseases of the Retina |
Webinar #22 Retinal Imaging in IRDs |
| Educational Programme Certificate |
After completion of webinars #1 to #3 and evaluation questionnaire |
After completion of webinars #4 to #6 and evaluation questionnaire |
After completion of webinars #4, #5 and #7 and evaluation questionnaire |
After completion of webinars #8 to #10 and evaluation questionnaire |
After completion of webinars #11 to #13 and evaluation questionnaire |
After completion of webinars #14 to #16 and evaluation questionnaire |
After completion of webinars #17 to #23 and evaluation questionnaire |
